Paper18242512
Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation.
Zheng H and 6 others. Cancer Cell, 2008. Cited by 126 papers, by iCite.
Cite this record
ConductScience Library. Induction of abnormal proliferation by nonmyelinating schwann cells triggers neurofibroma formation. Papers, record 18242512. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18242512
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Myelin Sheath | Major topic |
| Neurofibroma | Major topic |
| Schwann Cells | Major topic |
| Animals | |
| Biomarkers | |
| Cell Lineage | |
| Cell Proliferation | |
| Disease Progression | |
| Fetus | |
| Gene Targeting | |
| Glial Fibrillary Acidic Protein | |
| Integrases | |
| Mice | |
| Mutation | |
| Neurofibromin 1 | |
| Receptor, Nerve Growth Factor | |
| Recombination, Genetic | |
| Sciatic Nerve | |
| Stem Cells |
Source PubMed
Cited by87
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 126 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40553452 | MTA-Cooperative PRMT5 Inhibitors Are Efficacious in MTAP-Deleted Malignant Peripheral Nerve Sheath Tumor Models. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40553452 | PubMed |
| 40075752 | Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40075752 | PubMed |
| 39413183 | Stimulator of interferon gene facilitates recruitment of effector CD8 T cells that drive neurofibromatosis type 1 nerve tumor initiation and maintenance. | Sci Adv | 2024 | https://conductscience.org/library/papers/39413183 | PubMed |
| 38473354 | The NF1+/- Immune Microenvironment: Dueling Roles in Neurofibroma Development and Malignant Transformation. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38473354 | PubMed |
| 38353122 | Stem cell modeling of nervous system tumors. | Dis Model Mech | 2024 | https://conductscience.org/library/papers/38353122 | PubMed |
| 38086379 | Econazole selectively induces cell death in NF1-homozygous mutant tumor cells. | Cell Rep Med | 2023 | https://conductscience.org/library/papers/38086379 | PubMed |
| 37686382 | Identification of an NF1 Microdeletion with Optical Genome Mapping. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37686382 | PubMed |
| 37246765 | Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology. | Neuro Oncol | 2023 | https://conductscience.org/library/papers/37246765 | PubMed |
| 37140985 | Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37140985 | PubMed |
| 36327093 | Role of nerves in neurofibromatosis type 1-related nervous system tumors. | Cell Oncol (Dordr) | 2022 | https://conductscience.org/library/papers/36327093 | PubMed |
| 36263368 | A physical perspective to understand myelin II: The physical origin of myelin development. | Front Neurosci | 2022 | https://conductscience.org/library/papers/36263368 | PubMed |
| 36139671 | Neurofibroma Development in Neurofibromatosis Type 1: Insights from Cellular Origin and Schwann Cell Lineage Development. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36139671 | PubMed |
| 36134665 | Multiple Nf1 Schwann cell populations reprogram the plexiform neurofibroma tumor microenvironment. | JCI Insight | 2022 | https://conductscience.org/library/papers/36134665 | PubMed |
| 35311647 | P2RY14 cAMP signaling regulates Schwann cell precursor self-renewal, proliferation, and nerve tumor initiation in a mouse model of neurofibromatosis. | Elife | 2022 | https://conductscience.org/library/papers/35311647 | PubMed |
| 35244537 | Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma. | Elife | 2022 | https://conductscience.org/library/papers/35244537 | PubMed |
| 34722092 | Malignant Peripheral Nerve Sheath Tumor Presenting as Horner's Syndrome. | Cureus | 2021 | https://conductscience.org/library/papers/34722092 | PubMed |
| 34604833 | Insights into the Pathogenesis of NF1-Associated Neoplasms. | JID Innov | 2021 | https://conductscience.org/library/papers/34604833 | PubMed |
| 34345017 | Tumorigenesis in neurofibromatosis type 1: role of the microenvironment. | Oncogene | 2021 | https://conductscience.org/library/papers/34345017 | PubMed |
| 33951044 | Genotype-phenotype correlation in neurofibromatosis type-1: NF1 whole gene deletions lead to high tumor-burden and increased tumor-growth. | PLoS Genet | 2021 | https://conductscience.org/library/papers/33951044 | PubMed |
| 33850471 | Increased nuclear translation of YAP might act as a potential therapeutic target for NF1-related plexiform neurofibroma. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33850471 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| NF1 | 4763 | PubTator's text mining | https://conductscience.org/library/genes/4763 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18242512
GET https://conductscience.org/api/papers/v1/18242512/cited_by?page=2